PERRIGO Co plc (PRGO) stock
PRGONYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3029% below fair value
$16.24+0.06 (+0.37%)
Close on Nov 13, 2026Market cap $2.25BP/E –Yield 7.14%
Perrigo enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Perrigo's enterprise value was $5.15B on Nov 11, 2026, against $5.05B a year earlier. Over the last 5 years it ranged from $4.59B to $9.03B, with a median of $6.91B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $5.15B | +0.5% |
| 2025 | Dec 31, 2025 | $5.13B | -24.6% |
| 2024 | Dec 31, 2024 | $6.80B | -13.5% |
| 2023 | Dec 29, 2023 | $7.86B | -4.4% |
| 2022 | Dec 30, 2022 | $8.22B | +22.7% |
| 2021 | Dec 31, 2021 | $6.70B | -24.4% |
| 2020 | Dec 31, 2020 | $8.86B | -11.5% |
| 2019 | Dec 31, 2019 | $10.02B | +21.6% |
| 2018 | Dec 31, 2018 | $8.23B | -45.8% |
| 2017 | Dec 29, 2017 | $15.19B | -12.8% |
| 2016 | Dec 30, 2016 | $17.42B | -34.0% |
| 2015 | Dec 31, 2015 | $26.42B | +7.0% |
| 2014 | Dec 31, 2014 | $24.68B | – |
| 2013 | Dec 31, 2013 | -$816.29M | – |
See a number that looks wrong?